Ellevest Inc’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Ellevest Inc’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25	Closed	-$2K	–	1974
2022 Q2	$2K	Hold	25	–	–	﹤0.01%	1195
2022 Q1	$1K	Buy	+25	New	+$840	﹤0.01%	1372
2021 Q4	–	Sell	-132	Closed	-$9K	–	1753
2021 Q3	$9K	Buy	132 +54	+69%	+$3.85K	﹤0.01%	853
2021 Q2	$6K	Buy	+78	New	+$5.76K	﹤0.01%	882
2020 Q1	–	Sell	-7	Closed	–	–	1366
2019 Q4	$0	Hold	7	–	–	﹤0.01%	1082
2019 Q3	$0	Buy	+7	New	+$305	﹤0.01%	630

Ellevest Inc's TPTX Position: Q3 2022 in Review

Ellevest Inc sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 25 shares — an estimated $2K sold.

Ellevest Inc first reported a position in TPTX in Q3 2019 and held it in 6 quarters. The position peaked at $9K in Q3 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Ellevest Inc reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Ellevest Inc sold 25 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2K.
Ellevest Inc first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
Ellevest Inc's Turning Point Therapeutics, Inc. Common Stock position peaked at $9K in Q3 2021.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.